Lan Lucy, Sikov Jennifer, Lejeune Julia, Ji Chelsea, Brown Hannah, Bullock Kim, Spencer Andrea E
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd, Stanford, CA 94304 USA.
Department of Psychology, Florida International University, Miami, Fl USA.
Curr Treat Options Psychiatry. 2023 Jun 14:1-21. doi: 10.1007/s40501-023-00287-5.
Immersive virtual reality (VR) and augmented reality (AR) have the potential to improve the treatment and diagnosis of individuals experiencing psychosis. Although commonly used in creative industries, emerging evidence reveals that VR is a valuable tool to potentially improve clinical outcomes, including medication adherence, motivation, and rehabilitation. However, the efficacy and future directions of this novel intervention require further study. The aim of this review is to search for evidence of efficacy in enhancing existing psychosis treatment and diagnosis with AR/VR.
2069 studies involving AR/VR as a diagnostic and treatment option were reviewed via PRISMA guidelines in five databases: PubMed, PsychInfo, Embase, and CINAHL.
Of the initial 2069 articles, 23 original articles were eligible for inclusion. One study applied VR to the diagnosis of schizophrenia. Most studies demonstrated that the addition of VR therapies and rehabilitation methods to treatment-as-usual (medication, psychotherapy, social skills training) was more effective than traditional methods alone in treating psychosis disorders. Studies also support the feasibility, safety, and acceptability of VR to patients. No articles using AR as a diagnostic or treatment option were found.
VR is efficacious in diagnosing and treating individuals experiencing psychosis and is a valuable augmentation of evidence-based treatments.
The online version contains supplementary material available at 10.1007/s40501-023-00287-5.
沉浸式虚拟现实(VR)和增强现实(AR)有潜力改善精神病患者的治疗和诊断。尽管VR在创意产业中常用,但新出现的证据表明,VR是一种有价值的工具,有可能改善临床结果,包括药物依从性、动机和康复。然而,这种新型干预措施的疗效和未来方向需要进一步研究。本综述的目的是寻找使用AR/VR增强现有精神病治疗和诊断效果的证据。
通过PRISMA指南在五个数据库(PubMed、PsychInfo、Embase和CINAHL)中检索了2069项涉及将AR/VR作为诊断和治疗选择的研究。
在最初的2069篇文章中,有23篇原创文章符合纳入标准。一项研究将VR应用于精神分裂症的诊断。大多数研究表明,在常规治疗(药物治疗、心理治疗、社交技能训练)中增加VR疗法和康复方法比单独使用传统方法治疗精神病更有效。研究还支持VR对患者的可行性、安全性和可接受性。未发现使用AR作为诊断或治疗选择的文章。
VR在诊断和治疗精神病患者方面是有效的,并且是基于证据的治疗方法的有价值补充。
在线版本包含可在10.1007/s40501-023-00287-5获取的补充材料。